Analysts have updated their price targets for NuVasive shares, according to Fiscal Standard.
Here are three quick points:
1. Jeffries analysts reiterated their "buy" rating for NuVasive stock with a price target of $72, on July 27.
2. Barclays analysts reiterated their "overweight" rating for NuVasive shares with a price target of $71, on July 27.
3. On July 27, Brean Capital analysts reiterated their "buy" rating for NuVasive stock with a price target of $70.